PROCEEDINGS VOLUME 4156
EOS/SPIE EUROPEAN BIOMEDICAL OPTICS WEEK | 4-8 JULY 2000
Clinical Lasers and Diagnostics
IN THIS VOLUME

0 Sessions, 48 Papers, 0 Presentations
Gynecology  (4)
Neurosurgery  (3)
Laser Safety  (8)
Dentistry  (1)
Urology  (7)
EOS/SPIE EUROPEAN BIOMEDICAL OPTICS WEEK
4-8 July 2000
Amsterdam, Netherlands
PDT-Biochemistry
Proc. SPIE 4156, Differential accumulation and organ-specific metabolism of 5-aminolevulinic acid between cancer cells and normal epithelial and stromal cells, 0000 (31 January 2001); doi: 10.1117/12.413718
Proc. SPIE 4156, Formation of 5-aminolevulinic-acid (ALA) induced protoporphyrin IX (PPIX) and photodynamic effectiveness in human urothelial cell lines, 0000 (31 January 2001); doi: 10.1117/12.413722
Proc. SPIE 4156, Different pathways of tumor damage due to PDT: the influence of parameters of laser irradiation, 0000 (31 January 2001); doi: 10.1117/12.413726
Proc. SPIE 4156, Optimization of photodynamic therapy: the influence of photosensitizer uptake and distribution on tumor response, 0000 (31 January 2001); doi: 10.1117/12.413734
Proc. SPIE 4156, Site-specific tumor-targeted fluorescent contrast agents, 0000 (31 January 2001); doi: 10.1117/12.413736
Proc. SPIE 4156, Effect of thrombocytopenia on the efficacy of Photofrin-based photodynamic therapy in vivo, 0000 (31 January 2001); doi: 10.1117/12.413697
Proc. SPIE 4156, Novel photosensitizers for prospective clinical usage and some of their properties, 0000 (31 January 2001); doi: 10.1117/12.413699
Proc. SPIE 4156, Singlet oxygen: Is it useful for PDT?, 0000 (31 January 2001); doi: 10.1117/12.413706
Proc. SPIE 4156, Phototoxic properties of dibiotinylated aluminum sulphophthalocyanine in vitro and in vivo, 0000 (31 January 2001); doi: 10.1117/12.413716
Gynecology
Proc. SPIE 4156, 5-aminolevulinic-acid (ALA) induced fluorescence for laparoscopic diagnosis of peritoneal metastasis: an experimental study, 0000 (31 January 2001); doi: 10.1117/12.413717
Proc. SPIE 4156, State of some peripheral organs during laser puncture correction of ovarian functional deficiency, 0000 (31 January 2001); doi: 10.1117/12.413719
Proc. SPIE 4156, Autofluorescence diagnostic of gynecological diseases ex vivo, 0000 (31 January 2001); doi: 10.1117/12.413720
Proc. SPIE 4156, Photodynamic therapy in a cervico-uterine cancer cell line (HeLa) implanted in nu/nu mice, 0000 (31 January 2001); doi: 10.1117/12.413721
Neurosurgery
Proc. SPIE 4156, Clinical results of stereotactic intratumoral photodynamic therapy for malignant brain tumors, 0000 (31 January 2001); doi: 10.1117/12.413723
Proc. SPIE 4156, Stereotactic-guided laser-induced interstitial thermotherapy (SLITT) in gliomas with intraoperative morphologic monitoring in open MR, 0000 (31 January 2001); doi: 10.1117/12.413724
Proc. SPIE 4156, Stereotactic use of the 980-nm diode laser in rat cortical and subcortical tissues, 0000 (31 January 2001); doi: 10.1117/12.413725
Laser Safety
Proc. SPIE 4156, English and updated edition of the report "Laser Safety in Health Care" of the Dutch Committee on Laser Safety in Health Care, 0000 (31 January 2001); doi: 10.1117/12.413727
Proc. SPIE 4156, Risk assessment methodology for laser applications in medicine, 0000 (31 January 2001); doi: 10.1117/12.413728
Proc. SPIE 4156, Factors affecting morbidity and complications of laser therapy, 0000 (31 January 2001); doi: 10.1117/12.413729
Proc. SPIE 4156, Systematic assessment of laser safety in otolaryngology, 0000 (31 January 2001); doi: 10.1117/12.413730
Proc. SPIE 4156, Assessment of the risk from laser pointers, 0000 (31 January 2001); doi: 10.1117/12.413731
Proc. SPIE 4156, Potential health hazard of gene transformation of survived cells by pilot and scattered radiation of surgical lasers, 0000 (31 January 2001); doi: 10.1117/12.413732
Proc. SPIE 4156, Shaping the Romanian laser safety policy in the frame of European cooperation, 0000 (31 January 2001); doi: 10.1117/12.413733
Proc. SPIE 4156, Multimedia concept for laser safety trainin meeting the individual user's requirements, 0000 (31 January 2001); doi: 10.1117/12.413735
ENT & Head and Neck
Proc. SPIE 4156, Cryolaser segmentary lacunotomy of palatine tonsils, 0000 (31 January 2001); doi: 10.1117/12.413737
Proc. SPIE 4156, Compact self-contained blood coagulator based on semiconductor laser, 0000 (31 January 2001); doi: 10.1117/12.413738
Dentistry
Proc. SPIE 4156, Monitoring the stress build-up in dental cements: a novel optical characterization technique, 0000 (31 January 2001); doi: 10.1117/12.413691
Ophthalmology
Proc. SPIE 4156, New multichannel DSP-based laser Doppler flowmetry analysis system for quantification of ocular blood flow, 0000 (31 January 2001); doi: 10.1117/12.413692
Proc. SPIE 4156, Speckle technologies and measurement of retinal visual acuity in cataract patients, 0000 (31 January 2001); doi: 10.1117/12.413693
Proc. SPIE 4156, Accuracy of modal wavefront estimation from eye transverse aberration measurements, 0000 (31 January 2001); doi: 10.1117/12.413694
Proc. SPIE 4156, Influence of eye micromotions on spatially resolved refractometry, 0000 (31 January 2001); doi: 10.1117/12.413695
Proc. SPIE 4156, Role of intraocular lens parameters in visual rehabilitation of patients after extracapsular cataract extraction, 0000 (31 January 2001); doi: 10.1117/12.413696
Cardiovascular
Proc. SPIE 4156, Endovascular photodynamic therapy inhibits intimal hyperplasia PTA in a rat model, 0000 (31 January 2001); doi: 10.1117/12.413698
Proc. SPIE 4156, Mid-infrared lasers for transmyocardial laser revascularization, 0000 (31 January 2001); doi: 10.1117/12.413700
Urology
Proc. SPIE 4156, Using radiance predicted by the P3 approximation in a spherical geometry to predict tissue optical properties, 0000 (31 January 2001); doi: 10.1117/12.413701
Proc. SPIE 4156, Efficiency of complicated kidney tuberculosis chemotherapy in combination with low-level laser therapy, 0000 (31 January 2001); doi: 10.1117/12.413702
Proc. SPIE 4156, Spectral and imaging fluorescence analysis with ALA-induced protoporphyrin IX with the aim to increase the efficiency of bladder transurethral resections, 0000 (31 January 2001); doi: 10.1117/12.413703
Proc. SPIE 4156, Efficiency of autofluorescence diagnosis and photodynamic therapy (PDT) of bladder tumors: our own experience, 0000 (31 January 2001); doi: 10.1117/12.413704
Proc. SPIE 4156, Using alpha-interferon as an adjunctive therapy to reduce the dose of energy required with photodynamic therapy in treating human bladder tumors: cell culture results, 0000 (31 January 2001); doi: 10.1117/12.413705
Proc. SPIE 4156, Sequential whole bladder photodynamic therapy (WBPT) in the management of recurrent superficial bladder cancer, 0000 (31 January 2001); doi: 10.1117/12.413707
Proc. SPIE 4156, Low-level laser as a device for increase of drug concentration in the kidney, 0000 (31 January 2001); doi: 10.1117/12.413708
Gastroenterology
Proc. SPIE 4156, Fluorescence staging laparoscopy for gastrointestinal malignancies: experimental experience, 0000 (31 January 2001); doi: 10.1117/12.413709
Proc. SPIE 4156, Endoscopic detection of early malignancies in the upper gastrointestinal tract using laser-induced fluorescence imaging, 0000 (31 January 2001); doi: 10.1117/12.413710
Proc. SPIE 4156, Esophageal photodynamic therapy with mTHPC (m-tetra hydroxyphenyl chlorin) using a laser and a nonlaser light source: a pilot study, 0000 (31 January 2001); doi: 10.1117/12.413711
Proc. SPIE 4156, Application of 5-ALA for differential diagnostics of stomach diseases, 0000 (31 January 2001); doi: 10.1117/12.413712
Proc. SPIE 4156, Laser-induced fluorescent endoscopy (LIFE) in detection of malignant lesions of the colon, 0000 (31 January 2001); doi: 10.1117/12.413713
Proc. SPIE 4156, Mortality in experimental adjuvant intraoperative photodynamic therapy (AIOPDT) using ALA, Photofrin II, and mTHPC, 0000 (31 January 2001); doi: 10.1117/12.413714
Proc. SPIE 4156, Adjuvant intraoperative photodynamic therapy (AIOPDT) after photosensitization with mTHPC in a CC531 colon carcinoma model in mice, 0000 (31 January 2001); doi: 10.1117/12.413715
Back to Top